Skip to main content
OpenTrials
Completed

NCT Number: NCT05224284

BPA Levels Relationship With IVF/ICSI Outcomes in Patients With Male Factor

Association between blood and semen BPA levels and ICSI outcomes in patients with male factor

Completed

Looking for future studies?

Notify Me

Key information

Age range

23 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Nefise Nazlı YENIGUL

Bursa, 16110, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • female patients aged 23-40 years who underwent IVF due to male factor
  • men with semen sample obtained from ejaculate
  • male patients provided blood, and ejaculate samples on the oocyte retrieval day
  • patients who did not smoke or use alcohol
  • patients did not work in the plastic industry

Exclusion criteria

  • men with a diagnosis of azoospermia
  • patients who underwent IVF due to low ovarian reserve or unexplained infertility indications
  • patients diagnosed with endometriosis
  • patients with freeze-all cycles
  • women with metabolic disease (such as hypertension or diabetes mellitus)
  • patients (male or females) with a known genetic problem (male or female)

Treatment and study plan

BPA levels

Other

BPA (Bisfenol A) in blood and ejaculate samples

Primary outcomes

  1. Exposure to BPA

    Time frame: 6 month

    Concentrations of Bisphenol A (BPA) will be quantified in the blood plasma, and ejaculate (individual and pooled samples) by use of ELİSA test in women with male factor

Sponsors and collaborators

Lead sponsor

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Other

Registry information

Official study title

Impact of Blood and Ejaculate Bisphenol A Concentrations on ICSI Cycles Outcome in Patients With Male Factor

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Feb 4, 2022
Registry last updated
Feb 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.